Annotation (Toggle Detail/Summary View) Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | calyculin A inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in increased expression of MCL1 mRNA alternative form]; more ... | CTD | PMID:18348186 | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | CAT protein inhibits the reaction [epigallocatechin gallate analog results in decreased expression of MCL1 protein] | CTD | PMID:16115949 | (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate analog results in decreased expression of MCL1 protein | CTD | PMID:16115949 | (3S,5R)-fluvastatin | decreases expression | EXP | | 6480464 | fluvastatin results in decreased expression of MCL1 protein | CTD | PMID:16996129 | (S)-nicotine | increases phosphorylation | EXP | | 6480464 | Nicotine results in increased phosphorylation of MCL1 protein | CTD | PMID:19903766 | (S)-nicotine | multiple interactions | EXP | | 6480464 | [Nicotine results in increased phosphorylation of MCL1 protein] which results in increased expression of and results in increased stability of MCL1 protein; more ... | CTD | PMID:19903766 | 1-methylphenanthrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of MCL1 mRNA | CTD | PMID:17690111 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:735513 | 6480464 | Ethinyl Estradiol affects the expression of MCL1 mRNA | CTD | PMID:17555576 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of MCL1 mRNA | CTD | PMID:19426747 | 1H-pyrazole | increases expression | ISO | RGD:735513 | 6480464 | pyrazole results in increased expression of MCL1 mRNA | CTD | PMID:17945193 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MCL1 mRNA | CTD | PMID:17823287 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:735513 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MCL1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:620525 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MCL1 mRNA | CTD | PMID:19520675 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735513 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MCL1 mRNA | CTD | PMID:14718646 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:735513 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MCL1 mRNA | CTD | PMID:19465110 | 2,4-dinitrotoluene | affects expression | ISO | RGD:620525 | 6480464 | 2,4-dinitrotoluene affects the expression of MCL1 mRNA | CTD | PMID:21346803 | 2-amino-2-deoxy-D-glucopyranose | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of MCL1 mRNA; more ... | CTD | PMID:22020377 | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of MCL1 mRNA | CTD | PMID:21179406 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:735513 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of MCL1 mRNA | CTD | PMID:18648102 | 5-fluorouracil | affects expression | EXP | | 6480464 | Fluorouracil affects the expression of MCL1 protein | CTD | PMID:21036698 | 5-fluorouracil | decreases response to substance | EXP | | 6480464 | MCL1 protein results in decreased susceptibility to Fluorouracil | CTD | PMID:15262975 | 8'-apo-beta,psi-caroten-8'-al | affects expression | EXP | | 6480464 | apocarotenal affects the expression of MCL1 mRNA | CTD | PMID:17034753 | acetaldehyde | increases expression | EXP | | 6480464 | Acetaldehyde results in increased expression of MCL1 mRNA | CTD | PMID:23416264 | acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of MCL1 protein | CTD | PMID:19936928 | acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin results in increased degradation of and results in decreased expression of MCL1 protein | CTD | PMID:20116423 | actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [IL1B results in increased expression of MCL1 protein]; more ... | CTD | PMID:16492401 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MCL1 mRNA | CTD | PMID:21641981 | aldehydo-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of MCL1 mRNA; more ... | CTD | PMID:22020377 | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with TGFB1 protein] results in increased expression of MCL1 protein | CTD | PMID:16242776 | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | PI103 inhibits the reaction [Tretinoin results in increased expression of MCL1 protein] | CTD | PMID:19176369 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of MCL1 protein | CTD | PMID:16572199 PMID:19176369 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of MCL1 mRNA | CTD | PMID:17034753 | all-trans-retinoic acid | increases expression | ISO | RGD:735513 | 6480464 | Tretinoin results in increased expression of MCL1 mRNA | CTD | PMID:16604517 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of MCL1 protein | CTD | PMID:16572199 | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with zoledronic acid] results in decreased expression of MCL1 mRNA | CTD | PMID:20349282 | all-trans-retinol | affects expression | EXP | | 6480464 | Vitamin A affects the expression of MCL1 mRNA | CTD | PMID:17034753 | ammonium chloride | decreases expression | ISO | RGD:620525 | 6480464 | Ammonium Chloride results in decreased expression of MCL1 protein | CTD | PMID:16483693 | arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of MCL1 mRNA | CTD | PMID:11134558 | arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of MCL1 mRNA | CTD | PMID:18585952 | arsenite(3-) | multiple interactions | EXP | | 6480464 | XPA protein affects the reaction [arsenite results in increased expression of MCL1 mRNA] | CTD | PMID:18585952 | arsenite(3-) | multiple interactions | EXP | | 6480464 | [arsenite results in increased phosphorylation of EIF2S1 protein] which results in decreased expression of MCL1 protein; more ... | CTD | PMID:17553788 | arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of MCL1 protein | CTD | PMID:17553788 | auranofin | multiple interactions | EXP | | 6480464 | [Auranofin co-treated with SN50 peptide] results in decreased expression of MCL1 protein | CTD | PMID:20542334 | auranofin | decreases expression | EXP | | 6480464 | Auranofin results in decreased expression of MCL1 protein | CTD | PMID:20542334 | benzo[a]pyrene | multiple interactions | ISO | RGD:735513 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MCL1 mRNA | CTD | PMID:21715664 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MCL1 mRNA | CTD | PMID:16269432 more ... | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of MCL1 mRNA; more ... | CTD | PMID:17690111 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MCL1 mRNA | CTD | PMID:21632981 more ... | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MCL1 mRNA | CTD | PMID:21871943 PMID:22316170 | benzo[a]pyrene | increases expression | ISO | RGD:735513 | 6480464 | Benzo(a)pyrene results in increased expression of MCL1 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MCL1 mRNA | CTD | PMID:21871943 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with Nitrogen Oxides] results in increased expression of MCL1 protein | CTD | PMID:16041517 | benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of MCL1 mRNA | CTD | PMID:17690111 | beta-carotene | affects expression | EXP | | 6480464 | beta Carotene affects the expression of MCL1 mRNA | CTD | PMID:17034753 | beta-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of MCL1 mRNA; more ... | CTD | PMID:22020377 | bis(2-chloroethyl) sulfide | decreases expression | EXP | | 6480464 | Mustard Gas results in decreased expression of MCL1 mRNA | CTD | PMID:12884408 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MCL1 protein | CTD | PMID:21277958 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MCL1 mRNA | CTD | PMID:12760830 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of MCL1 | CTD | PMID:21787858 | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of MCL1 protein | CTD | PMID:12479363 | capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of MCL1 mRNA | CTD | PMID:19502594 | celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of MCL1 protein | CTD | PMID:19665451 more ... | celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of MCL1 protein | CTD | PMID:14654083 more ... | celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of MCL1 protein | CTD | PMID:19665451 more ... | celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of MCL1 protein | CTD | PMID:14654083 more ... | celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of MCL1 protein | CTD | PMID:14654083 more ... | celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of MCL1 protein | CTD | PMID:20836993 more ... | celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of MCL1 protein | CTD | PMID:20836993 more ... | chloroacetic acid | decreases expression | ISO | RGD:735513 | 6480464 | chloroacetic acid results in decreased expression of MCL1 mRNA | CTD | PMID:23103613 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin results in decreased susceptibility to Cisplatin] which results in decreased expression of MCL1 protein | CTD | PMID:21130731 | cisplatin | decreases response to substance | EXP | | 6480464 | MCL1 protein results in decreased susceptibility to Cisplatin | CTD | PMID:21507240 PMID:20802529 | cisplatin | decreases response to substance | EXP | | 6480464 | MCL1 protein results in decreased susceptibility to Cisplatin | CTD | PMID:20802529 PMID:21507240 | cisplatin | multiple interactions | EXP | | 6480464 | LGALS3 inhibits the reaction [Cisplatin results in increased degradation of MCL1 protein] | CTD | PMID:21821001 | cisplatin | increases degradation | EXP | | 6480464 | Cisplatin results in increased degradation of MCL1 protein | CTD | PMID:21821001 | clofibrate | increases expression | ISO | RGD:735513 | 6480464 | Clofibrate results in increased expression of MCL1 mRNA | CTD | PMID:17585979 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of MCL1 mRNA; more ... | CTD | PMID:15611089 | cobalt dichloride | increases cleavage | EXP | | 6480464 | cobaltous chloride results in increased cleavage of MCL1 protein | CTD | PMID:16374551 | copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of MCL1 mRNA | CTD | PMID:19549813 | crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of MCL1 mRNA | CTD | PMID:18687144 | curcumin | decreases expression | ISO | RGD:735513 | 6480464 | Curcumin results in decreased expression of MCL1 protein alternative form | CTD | PMID:18829502 | cycloheximide | multiple interactions | EXP | | 6480464 | [Cycloheximide co-treated with MCL1] results in increased susceptibility to ABT-737 | CTD | PMID:21880625 | cycloheximide | decreases expression | EXP | | 6480464 | Cycloheximide results in decreased expression of MCL1 protein | CTD | PMID:14982947 | cyclosporin A | decreases expression | ISO | RGD:735513 | 6480464 | Cyclosporine results in decreased expression of MCL1 mRNA | CTD | PMID:19770486 | cytarabine | decreases expression | EXP | | 6480464 | Cytarabine results in decreased expression of MCL1 protein | CTD | PMID:16818278 | dacarbazine | decreases response to substance | EXP | | 6480464 | MCL1 protein results in decreased susceptibility to Dacarbazine | CTD | PMID:12787138 | dasatinib (anhydrous) | decreases expression | EXP | | 6480464 | dasatinib results in decreased expression of MCL1 protein | CTD | PMID:18550857 | desferrioxamine B | multiple interactions | EXP | | 6480464 | Nitroprusside inhibits the reaction [Deferoxamine results in increased cleavage of MCL1 protein]; more ... | CTD | PMID:16374551 | desferrioxamine B | increases cleavage | EXP | | 6480464 | Deferoxamine results in increased cleavage of MCL1 protein | CTD | PMID:16374551 | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of MCL1 mRNA | CTD | PMID:16144937 | dexamethasone | increases expression | ISO | RGD:620525 | 6480464 | Dexamethasone results in increased expression of MCL1 mRNA | CTD | PMID:20032058 | dexamethasone | multiple interactions | ISO | RGD:620525 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of MCL1 mRNA] | CTD | PMID:20032058 | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of MCL1 protein | CTD | PMID:12883267 more ... | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of MCL1 protein | CTD | PMID:12883267 more ... | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of MCL1 protein | CTD | PMID:12883267 more ... | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of MCL1 protein | CTD | PMID:19364129 more ... | diarsenic trioxide | decreases expression | ISO | RGD:735513 | 6480464 | arsenic trioxide results in decreased expression of MCL1 mRNA | CTD | PMID:21533816 | diarsenic trioxide | increases expression | ISO | RGD:620525 | 6480464 | arsenic trioxide results in increased expression of MCL1 mRNA | CTD | PMID:19730151 | diarsenic trioxide | multiple interactions | ISO | RGD:735513 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of MCL1 mRNA] | CTD | PMID:21533816 | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of MCL1 mRNA | CTD | PMID:19549371 | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of MCL1 | CTD | PMID:21473291 | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of MCL1 protein | CTD | PMID:18349030 more ... | dibenz[a,h]anthracene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of MCL1 mRNA | CTD | PMID:17690111 | dibutyl phthalate | increases expression | ISO | RGD:735513 | 6480464 | Dibutyl Phthalate results in increased expression of MCL1 mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | ISO | RGD:620525 | 6480464 | Dibutyl Phthalate results in increased expression of MCL1 mRNA | CTD | PMID:21266533 | diethylstilbestrol | decreases expression | ISO | RGD:735513 | 6480464 | Diethylstilbestrol results in decreased expression of MCL1 mRNA | CTD | PMID:21041162 | diuron | decreases expression | ISO | RGD:620525 | 6480464 | Diuron results in decreased expression of MCL1 mRNA | CTD | PMID:21551480 | docetaxel anhydrous | increases expression | EXP | | 6480464 | docetaxel results in increased expression of MCL1 protein | CTD | PMID:17317842 | docetaxel anhydrous | multiple interactions | EXP | | 6480464 | U 0126 inhibits the reaction [docetaxel results in increased expression of MCL1 protein] | CTD | PMID:17317842 | doxorubicin | multiple interactions | EXP | | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Doxorubicin] results in decreased expression of MCL1 protein; more ... | CTD | PMID:20856197 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of MCL1 protein | CTD | PMID:20856197 PMID:17935137 | doxorubicin | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [Doxorubicin results in decreased expression of MCL1 protein] | CTD | PMID:17935137 | doxorubicin | decreases response to substance | EXP | | 6480464 | MCL1 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:20856197 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of MCL1 protein | CTD | PMID:17935137 PMID:20856197 | etoposide | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [Etoposide results in decreased expression of MCL1 protein] | CTD | PMID:17935137 | etoposide | decreases expression | EXP | | 6480464 | Etoposide results in decreased expression of MCL1 protein | CTD | PMID:17935137 | folic acid | affects expression | EXP | | 6480464 | Folic Acid affects the expression of MCL1 mRNA | CTD | PMID:16361273 | glycochenodeoxycholic acid | multiple interactions | EXP | | 6480464 | Glycochenodeoxycholic Acid inhibits the reaction [HUWE1 protein binds to MCL1 protein]; more ... | CTD | PMID:21507240 | glycochenodeoxycholic acid | increases phosphorylation | EXP | | 6480464 | Glycochenodeoxycholic Acid results in increased phosphorylation of MCL1 protein | CTD | PMID:21507240 | hydrogen chloride | decreases expression | EXP | | 6480464 | Hydrochloric Acid results in decreased expression of MCL1 mRNA | CTD | PMID:15046208 | ibuprofen | multiple interactions | EXP | | 6480464 | calyculin A inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in decreased expression of MCL1 mRNA alternative form]; more ... | CTD | PMID:18348186 | imatinib | multiple interactions | EXP | | 6480464 | [imatinib co-treated with flavopiridol] results in decreased expression of MCL1 protein; more ... | CTD | PMID:12231544 | isoflurane | decreases expression | ISO | RGD:620525 | 6480464 | Isoflurane results in decreased expression of MCL1 mRNA | CTD | PMID:16978161 | leukotriene B4 | increases expression | EXP | | 6480464 | Leukotriene B4 results in increased expression of MCL1 mRNA; more ... | CTD | PMID:15970427 | leukotriene B4 | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [Leukotriene B4 results in increased expression of MCL1 protein]; more ... | CTD | PMID:15970427 | lithium chloride | increases expression | EXP | | 6480464 | Lithium Chloride results in increased expression of MCL1 mRNA; more ... | CTD | PMID:22493441 | lithocholic acid | affects localization | ISO | RGD:735513 | 6480464 | Lithocholic Acid affects the localization of MCL1 protein | CTD | PMID:19433268 | lithocholic acid | increases expression | ISO | RGD:735513 | 6480464 | Lithocholic Acid results in increased expression of MCL1 mRNA | CTD | PMID:19433268 | lithocholic acid | multiple interactions | ISO | RGD:735513 | 6480464 | Phenobarbital inhibits the reaction [Lithocholic Acid results in increased expression of MCL1 mRNA]; more ... | CTD | PMID:19433268 | lonidamine | decreases expression | EXP | | 6480464 | lonidamine results in decreased expression of MCL1 protein | CTD | PMID:21889928 | LY294002 | decreases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MCL1 protein | CTD | PMID:17148679 | LY294002 | multiple interactions | EXP | | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of MCL1 mRNA; more ... | CTD | PMID:22046442 | LY294002 | affects expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the expression of MCL1 mRNA | CTD | PMID:22046442 | LY294002 | increases degradation | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased degradation of MCL1 protein | CTD | PMID:21821001 | LY294002 | multiple interactions | EXP | | 6480464 | LGALS3 inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased degradation of MCL1 protein] | CTD | PMID:21821001 | LY294002 | multiple interactions | EXP | | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Doxorubicin] results in decreased expression of MCL1 protein | CTD | PMID:20856197 | melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [oxaliplatin results in decreased expression of MCL1 protein] | CTD | PMID:20626587 | methotrexate | affects expression | ISO | RGD:735513 | 6480464 | Methotrexate affects the expression of MCL1 mRNA | CTD | PMID:18502557 | methylmercury(1+) | increases expression | ISO | RGD:620525 | 6480464 | methylmercury II results in increased expression of MCL1 mRNA | CTD | PMID:17905399 | monocrotophos | decreases expression | ISO | RGD:620525 | 6480464 | Monocrotophos results in decreased expression of MCL1 mRNA | CTD | PMID:20957986 | monocrotophos | decreases expression | ISO | RGD:620525 | 6480464 | Monocrotophos results in decreased expression of MCL1 protein | CTD | PMID:21445290 | monocrotophos | decreases expression | ISO | RGD:620525 | 6480464 | Monocrotophos results in decreased expression of MCL1 mRNA | CTD | PMID:20957986 PMID:21445290 | morphine | increases expression | ISO | RGD:735513 | 6480464 | Morphine results in increased expression of MCL1 mRNA | CTD | PMID:20144693 | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[bortezomib co-treated with Butyrates] results in decreased expression of MCL1 protein]; more ... | CTD | PMID:15173093 | N-acetyl-L-cysteine | multiple interactions | ISO | RGD:735513 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of MCL1 mRNA] | CTD | PMID:21533816 | nickel atom | increases expression | ISO | RGD:735513 | 6480464 | Nickel results in increased expression of MCL1 mRNA | CTD | PMID:12540486 | nickel dichloride | decreases expression | EXP | | 6480464 | nickel chloride results in decreased expression of MCL1 mRNA | CTD | PMID:17312168 | nitroprusside | multiple interactions | EXP | | 6480464 | Nitroprusside inhibits the reaction [Deferoxamine results in increased cleavage of MCL1 protein] | CTD | PMID:16374551 | ochratoxin A | increases expression | ISO | RGD:620525 | 6480464 | ochratoxin A results in increased expression of MCL1 mRNA | CTD | PMID:19562491 | oxaliplatin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [oxaliplatin results in decreased expression of MCL1 protein] | CTD | PMID:20626587 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of MCL1 protein | CTD | PMID:20626587 | paclitaxel | decreases expression | EXP | | 6480464 | Paclitaxel results in decreased expression of MCL1 protein | CTD | PMID:14749477 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of MCL1 mRNA | CTD | PMID:11896290 | paracetamol | multiple interactions | ISO | RGD:735513 | 6480464 | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of MCL1 mRNA] | CTD | PMID:18700144 | paracetamol | increases expression | ISO | RGD:735513 | 6480464 | Acetaminophen results in increased expression of MCL1 mRNA | CTD | PMID:18544908 | paracetamol | affects expression | ISO | RGD:735513 | 6480464 | Acetaminophen affects the expression of MCL1 mRNA | CTD | PMID:17562736 | paraoxon | multiple interactions | ISO | RGD:735513 | 6480464 | ACHE protein inhibits the reaction [Paraoxon results in decreased expression of MCL1 polyA tail] | CTD | PMID:22093924 | paraoxon | decreases expression | ISO | RGD:735513 | 6480464 | Paraoxon results in decreased expression of MCL1 polyA tail | CTD | PMID:22093924 | paraoxon | increases expression | ISO | RGD:735513 | 6480464 | Paraoxon results in increased expression of MCL1 protein alternative form | CTD | PMID:22093924 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of MCL1 mRNA | CTD | PMID:18836921 | pentobarbital | decreases expression | ISO | RGD:620525 | 6480464 | Pentobarbital results in decreased expression of MCL1 mRNA | CTD | PMID:16978161 | phenethyl isothiocyanate | decreases expression | EXP | | 6480464 | phenethyl isothiocyanate results in decreased expression of MCL1 protein | CTD | PMID:16054126 | phenobarbital | multiple interactions | ISO | RGD:735513 | 6480464 | Phenobarbital inhibits the reaction [Lithocholic Acid results in increased expression of MCL1 mRNA]; more ... | CTD | PMID:19433268 | phenobarbital | affects expression | ISO | RGD:735513 | 6480464 | Phenobarbital affects the expression of MCL1 mRNA | CTD | PMID:23091169 | phenol | decreases expression | EXP | | 6480464 | Phenol results in decreased expression of MCL1 mRNA | CTD | PMID:17547211 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MCL1 mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | RGD:735513 | 6480464 | pirinixic acid results in decreased expression of MCL1 mRNA | CTD | PMID:18445702 | pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:735513 | 6480464 | Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid affects the localization of MCL1 protein] | CTD | PMID:19433268 | propiconazole | decreases expression | ISO | RGD:735513 | 6480464 | propiconazole results in decreased expression of MCL1 mRNA | CTD | PMID:21278054 | propranolol | multiple interactions | EXP | | 6480464 | Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of MCL1 protein] | CTD | PMID:19903766 | pterostilbene | decreases expression | EXP | | 6480464 | pterostilbene results in decreased expression of MCL1 protein | CTD | PMID:23313376 | quercetin | multiple interactions | EXP | | 6480464 | MCL1 protein inhibits the reaction [Quercetin results in increased activity of CASP3 protein]; more ... | CTD | PMID:21138867 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of MCL1 protein | CTD | PMID:21138867 | quercetin | decreases response to substance | EXP | | 6480464 | MCL1 protein results in decreased susceptibility to Quercetin | CTD | PMID:21138867 | rel-(3R,5S)-fluvastatin | decreases expression | EXP | | 6480464 | fluvastatin results in decreased expression of MCL1 protein | CTD | PMID:16996129 | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [STAT3 protein results in increased expression of MCL1 protein] | CTD | PMID:16546976 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MCL1 protein | CTD | PMID:14749477 PMID:18347188 | resveratrol | increases degradation | EXP | | 6480464 | resveratrol results in increased degradation of MCL1 protein | CTD | PMID:22245142 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MCL1 protein | CTD | PMID:12902349 more ... | resveratrol | increases expression | ISO | RGD:735513 | 6480464 | resveratrol results in increased expression of MCL1 mRNA | CTD | PMID:16081268 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MCL1 protein | CTD | PMID:14749477 | romidepsin | multiple interactions | EXP | | 6480464 | romidepsin inhibits the reaction [bortezomib results in increased expression of MCL1 protein] | CTD | PMID:18223231 | sirolimus | multiple interactions | EXP | | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of MCL1 protein | CTD | PMID:15767555 | staurosporine | increases cleavage | EXP | | 6480464 | Staurosporine results in increased cleavage of MCL1 protein | CTD | PMID:16007152 | staurosporine | decreases response to substance | EXP | | 6480464 | MCL1 results in decreased susceptibility to Staurosporine | CTD | PMID:15217956 | tamoxifen | affects expression | ISO | RGD:735513 | 6480464 | Tamoxifen affects the expression of MCL1 mRNA | CTD | PMID:17555576 | tamoxifen | multiple interactions | EXP | | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of MCL1 mRNA; more ... | CTD | PMID:22046442 | tert-butyl hydroperoxide | multiple interactions | EXP | | 6480464 | [HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; more ... | CTD | PMID:15611089 | tert-butyl hydroperoxide | decreases response to substance | EXP | | 6480464 | MCL1 protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:15611089 | testosterone | multiple interactions | ISO | RGD:620525 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of MCL1 mRNA] | CTD | PMID:20032058 | tetrachloromethane | affects expression | ISO | RGD:620525 | 6480464 | Carbon Tetrachloride affects the expression of MCL1 mRNA | CTD | PMID:15963342 | thalidomide | decreases expression | EXP | | 6480464 | Thalidomide analog results in decreased expression of MCL1 protein | CTD | PMID:15858615 | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of MCL1 mRNA | CTD | PMID:17553788 | tocopherol | decreases response to substance | EXP | | 6480464 | MCL1 protein results in decreased susceptibility to Tocopherols | CTD | PMID:16001965 | trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [STAT3 protein results in increased expression of MCL1 protein] | CTD | PMID:16546976 | trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MCL1 protein | CTD | PMID:14749477 PMID:18347188 | trans-resveratrol | increases degradation | EXP | | 6480464 | resveratrol results in increased degradation of MCL1 protein | CTD | PMID:22245142 | trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MCL1 protein | CTD | PMID:12902349 more ... | trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MCL1 protein | CTD | PMID:14749477 | trans-resveratrol | increases expression | ISO | RGD:735513 | 6480464 | resveratrol results in increased expression of MCL1 mRNA | CTD | PMID:16081268 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of MCL1 protein | CTD | PMID:16009488 | triphenylstannane | increases expression | EXP | | 6480464 | triphenyltin results in increased expression of MCL1 mRNA | CTD | PMID:12788061 | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of MCL1 protein | CTD | PMID:17553788 | tunicamycin | multiple interactions | EXP | | 6480464 | [Tunicamycin results in increased phosphorylation of EIF2S1 protein] which results in decreased expression of MCL1 protein | CTD | PMID:17553788 | ursodeoxycholic acid | increases expression | EXP | | 6480464 | Ursodeoxycholic Acid analog results in increased expression of MCL1 protein | CTD | PMID:21146893 | valproic acid | decreases response to substance | ISO | RGD:735513 | 6480464 | MCL1 protein results in decreased susceptibility to Valproic Acid | CTD | PMID:19060243 | valproic acid | decreases expression | ISO | RGD:735513 | 6480464 | Valproic Acid results in decreased expression of MCL1 mRNA | CTD | PMID:15799026 PMID:20546886 | valproic acid | decreases expression | ISO | RGD:735513 | 6480464 | Valproic Acid results in decreased expression of MCL1 mRNA | CTD | PMID:15799026 | wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [Leukotriene B4 results in increased expression of MCL1 protein] | CTD | PMID:15970427 | wortmannin | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [Doxorubicin results in decreased expression of MCL1 protein]; more ... | CTD | PMID:17935137 | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of MCL1 mRNA | CTD | PMID:18356318 | zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of MCL1 mRNA | CTD | PMID:12107073 | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of MCL1 mRNA | CTD | PMID:18593933 | zinc atom | decreases expression | ISO | RGD:735513 | 6480464 | Zinc deficiency results in decreased expression of MCL1 mRNA | CTD | PMID:11739864 | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of MCL1 mRNA | CTD | PMID:18356318 | zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of MCL1 mRNA | CTD | PMID:12107073 | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of MCL1 mRNA | CTD | PMID:18593933 | zinc(0) | decreases expression | ISO | RGD:735513 | 6480464 | Zinc deficiency results in decreased expression of MCL1 mRNA | CTD | PMID:11739864 | zoledronic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with zoledronic acid] results in decreased expression of MCL1 mRNA | CTD | PMID:20349282 | |
Gene Ontology AnnotationsBiological Process











